Abbott and New Global Consortium Partnership Address Viral Outbreaks Caused by Climate Change Pharmaceutical Investing
BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference Pharmaceutical Investing
Gilead Sciences: Breaking Down Barriers To Access in HIV and Beyond: A Perspective Pharmaceutical Investing
Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business Pharmaceutical Investing
Jamieson Wellness Inc. Announces Date of First Quarter 2023 Financial Results and Conference Call Life Science Investing
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health Pharmaceutical Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: BELLUS Health Inc , Prometheus Biosciences, Inc. , Univar Solutions Inc. Life Science Investing
Knight to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference Pharmaceutical Investing
Antibe to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference Life Science Investing
